Patents by Inventor S. Rapoport

S. Rapoport has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ISOLATED RENAL CELLS AND USES THEREOF
    Publication number: 20240108657
    Abstract: The invention is directed to isolated renal cells, including tubular and erythropoietin (EPO)-producing kidney cell populations, and methods of isolating and culturing the same, as well as methods of treating a subject in need with the cell populations.
    Type: Application
    Filed: October 10, 2023
    Publication date: April 4, 2024
    Inventors: Sharon C. Presnell, Andrew T. Bruce, Shay M. Wallace, Sumana Choudhury, Russell W. Kelley, Manuel J. Jayo, Jessica J. Reinsch, Patricia D. Tatsumi, Timothy A. Bertram, Eric S. Werdin, Oluwatoyin A. Knight, H. Scott Rapoport, Roger M. Ilagan
  • Bioprinted hair follicles and uses thereof
    Patent number: 11850330
    Abstract: Disclosed are compositions comprising cellular constructs comprising mesenchymal cells and epithelial cells. Also disclosed are methods of making the cellular constructs, methods of hair restoration, and kits. The invention also discloses parallel bio-printing systems and methods for making cellular constructs, such as cellular constructs comprising mesenchymal cells and epithelial cells.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: December 26, 2023
    Assignee: Organovo, Inc.
    Inventors: Emily Bozek, Jonah Cool, Harry S. Rapoport, Christian Holmes, Stephen L. Pentoney, Chad Viergever, Howard Hwang, Christopher Shaw
  • Bioprinted Hair Follicles and Uses Thereof
    Publication number: 20190275208
    Abstract: Disclosed are compositions comprising cellular constructs comprising mesenchymal cells and epithelial cells. Also disclosed are methods of making the cellular constructs, methods of hair restoration, and kits. The invention also discloses parallel bio-printing systems and methods for making cellular constructs, such as cellular constructs comprising mesenchymal cells and epithelial cells.
    Type: Application
    Filed: November 10, 2017
    Publication date: September 12, 2019
    Inventors: Emily BOZEK, Jonah COOL, Harry S. RAPOPORT, Christian HOLMES, Stephen L. PENTONEY, Chad VIERGEVER, Howard HWANG, Christopher SHAW
  • Phenylcarbamates of (-)-eseroline, (-)-N1-noreseroline and (-)-N1-benzylnoreseroline: selective inhibitors of acetyl and butyrylcholinesterase, pharmaceutical compositions and method of use thereof
    Patent number: 5998460
    Abstract: The present invention relates to eseroline, N.sup.1 -noreseroline, and N.sup.1 -benzylnoreseroline phenyl carbamate analogues which provide highly potent and selective cholinergic agonist and blocking activity and their use as pharmaceutical agents. The invention further relates to improvements in therapeutic methods related to diseases such as glaucoma, myasthenia gravis, alzheimer's disease and to improvements in therapy related to organophosphate poisoning. The invention further provides for selective acetyl-cholinesterase and butyrylcholinesterase agents and a method for inhibiting these esterases.
    Type: Grant
    Filed: July 26, 1993
    Date of Patent: December 7, 1999
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Arnold Brossi, Malgarzota Brzostowska, S. Rapoport, Nigel Greig